SEC Form 5 · accession 0001104659-18-007629
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Yancopoulos
Officer — President and CSO · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 8, 2018 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2017 | W | 847 | $0.00 | A | 423,609 | D | |
| Common Stock | holding | — | — | — | 323,777 | I | by GRAT | |
| Common Stock | holding | — | — | — | 176,223 | I | by GRAT | |
| Common Stock | holding | — | — | — | 5,702 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 64,058 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.